Telepsychiatry for Mental Illness

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Mental IllnessTelepsychiatry - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is investigating whether a new method of psychiatric consultation called Asynchronous Telepsychiatry (ATP) is as effective as the current standard, Synchronous Telepsychiatry (STP).

Eligible Conditions
  • Mental Illness

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Change from baseline measure at 1-, 2-, 3-, 6- and 12-months

Change from baseline measure at 1-, 2-, 3-, 6- and 12-months
Clinical Global Impression (CGI)- severity scale
Patient Satisfaction Rating

Trial Safety

Trial Design

2 Treatment Groups

Synchronous Telepsychiatry (STP) group
1 of 2
Asynchronous Telepsychiatry (ATP) group
1 of 2

Active Control

Experimental Treatment

235 Total Participants · 2 Treatment Groups

Primary Treatment: Telepsychiatry · No Placebo Group · N/A

Asynchronous Telepsychiatry (ATP) group
Behavioral
Experimental Group · 1 Intervention: Telepsychiatry · Intervention Types: Behavioral
Synchronous Telepsychiatry (STP) group
Behavioral
ActiveComparator Group · 1 Intervention: Telepsychiatry · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telepsychiatry
2017
N/A
~360

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline measure at 1-, 2-, 3-, 6- and 12-months

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
364 Previous Clinical Trials
7,009,420 Total Patients Enrolled
University of California, DavisLead Sponsor
843 Previous Clinical Trials
5,012,116 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: